Amoxicillin and Protein-losing gastroenteropathy - a phase IV clinical study of FDA data
Summary:
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Amoxicillin?
Amoxicillin has active ingredients of amoxicillin. It is used in infection. Currently, eHealthMe is studying from 93,500 Amoxicillin users.
What is Protein-losing Gastroenteropathy?
Protein-losing gastroenteropathy (gastrointestinal tract that results in a net loss of protein from the body) is found to be associated with 306 drugs and 207 conditions by eHealthMe. Currently, we are studying 677 people who have Protein-losing gastroenteropathy.
Do you take Amoxicillin and have Protein-losing gastroenteropathy?
Check whether Protein-losing gastroenteropathy is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Amoxicillin side effects by duration, gender and age:
- Amoxicillin side effects (93,500 reports)
Protein-losing gastroenteropathy treatments and more:
- Protein-losing gastroenteropathy (677 reports)
All the drugs that are associated with Protein-losing gastroenteropathy:
All the conditions that are associated with Protein-losing gastroenteropathy:
How the study uses the data?
The study uses data from the FDA. It is based on amoxicillin (the active ingredients of Amoxicillin) and Amoxicillin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Mirtazapine and Trilipix drug interaction - a second ago
- Tobradex and Nosebleed - 4 seconds ago
- Oxervate and Oxybutynin Chloride drug interaction - 4 seconds ago
- Ranitidine and Spinal Cord Trauma - 13 seconds ago
- Combivir and Besivance drug interaction - 15 seconds ago
- Boswellia and Omeprazole drug interaction - 31 seconds ago
- Gliclazide and Throat Tightness - 39 seconds ago
- Piperacillin and Glipizide drug interaction - 47 seconds ago
- Vesicare and Hypoglycemia - 52 seconds ago
- Cafergot and Stress And Anxiety - 53 seconds ago